Continue to site >
Trending ETFs

News

Pfizer Inc. Beats Q4 Estimates (PFE)

Before Tuesday’s opening bell, Pfizer Inc. (PFE ) released its fourth quarter financial results, reporting a drop in profit.

PFE's Earnings in Brief

  • The company reported net income of $1.228 billion, or 19 cents per share, compared to $2.568 billion, or 39 cents per share, last year.
  • Excluding special items, earnings were 54 cents per share – above analysts’ view of 53 cents per share.
  • Revenue came in at $13.12 billion, up from $13.56 billion last year. Analysts expected to see revenue of $12.90 billion.
  • Looking forward, the company expects to see FY2015 revenue between $44.5 billion and $46.5 billion, and adjusted earnings between $2.00 and $2.10 per share. On average, analysts expect to see $47.56 billion in revenue and EPS of $2.18.

PFE's Dividend

Pfizer will pay its next 28 cent quarterly dividend on March 3. The stock will go ex-dividend on February 4.

Stock Performance

Shares of PFE were down 30 cents, or 0.91%, during pre-market trading Tuesday.

PFE Dividend Snapshot

As of market close on January 26, 2015


PFE dividend yield annual payout payout ratio dividend growth


Click here to see the complete history of PFE dividends.

The Bottom Line


Pfizer (PFE ) is recommended at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.